Nous avons remarqué que vous aviez consulté notre site internet depuis le pays États-Unis.
Nous proposons une version du site internet propre à votre pays (États-Unis).

Passer à États-Unis
Customer-service

Nous avons suscité votre intérêt ? Contactez-nous

Nous serons ravis de vous aider et nous vous répondrons dès que possible. 
Question

Une question ou un commentaire ? Notre assistance téléphonique est ouverte

Si vous avez besoin d'aide, notre équipe multinationale et nos experts locaux se tiennent prêts. N'hésitez pas à nous donner votre avis : il nous aide à nous améliorer.

Assistance téléphonique
Laissez un avis sur un produit
Ressources

Besoin d'un document ? Utilisez le centre de ressources

Accédez à l'ensemble des documents, vidéos, articles, modules d'e-learning et autres ressources relatives à tous nos produits.
Logo Hamilton Medical Hamilton Logo
 Pages d'accueil

HAMILTON-T1 neonatal ventilator. Transport ventilation for the little ones

HAMILTON-T1 with the neonatal option HAMILTON-T1 with the neonatal option

For your smallest patients. The neonatal option

The HAMILTON‑T1 with the neonatal option is an intelligent transport ventilator that provides ventilation therapy for your smallest and most fragile patients during transport. Thanks to its unique properties, the HAMILTON‑T1 performs like a fully featured NICU ventilator at the bedside – even during transport.

  • Conventional and modern ventilation modes for neonates

  • Noninvasive ventilation and integrated high flow nasal cannula therapy(Not available in all marketsa​)

  • CPR ventilation with integrated CO2 monitoring

  • Tidal volumes as low as 2 ml

  • Optimal synchronization using the neonatal proximal flow sensor

  • Specifically designed convenience sets including circuits, expiratory valve, and flow sensor

  • Volume Support mode

  • OSI Score (oxygen saturation index)

  • TI max (maximum inspiratory time)

Neonatal patient with Nuflow interface and mother

Careful, not too much! Tidal volumes as low as 2 ml

With the neonatal option, the HAMILTON-T1 provides tidal volumes as low as 2 ml for effective, safe, and lung-protective ventilation for neonates (Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666. Published 2010 Nov 10. doi:10.1002/14651858.CD003666.pub31​).

Adaptive synchronization. Even with uncuffed tubes

Leaks may occur when ventilating neonates due to the use of uncuffed tubes. The IntelliTrig leak compensation function automatically adjusts the inspiratory and expiratory trigger sensitivity to leaks. This enables adaptive synchronization with the neonate’s breathing pattern.

Neonatal patient on a ventilator intubated and with a flow sensor

Precision is vital. Proximal flow measurements

The proximal flow sensor and expiratory valve enable the precise measurement of pressure and flow directly at the airway opening, ensuring the required sensitivity and a quick response time.

Neonatal expiratory valve set

Accuracy is the key. The neonatal expiratory valve

To meet the stringent requirements regarding the pressure accuracy at minimum volumes, we have developed an expiratory valve especially for neonatal ventilation.

This valve can compensate for even the most minute pressure differences and enables the neonate to breathe spontaneously in each phase of a controlled breath cycle.

Trisha Degoyer

Témoignages de clients

Pouvoir utiliser la nCPAP avec le HAMILTON‑T1 est un réel avantage pour nous. Nous n'avons plus besoin d'intuber certains bébés juste pour le transport.

Trisha Degoyer

Infirmière diplômée en néonatalogie Life Flight
Intermountain Life Flight, Salt Lake City (Utah), États-Unis

Neonatal patient with nCPAP interface

Breathe easily. Neonatal ventilation modes

The HAMILTON‑T1 offers the option of noninvasive and invasive ventilation, with conventional and advanced ventilation modes for even the smallest patients.

The HAMILTON‑T1 is a state‑of‑the‑art ventilator offering a range of standard invasive ventilation modes for neonatal patients. These include pressure‑controlled modes (PCV+, PSIMV+, DuoPAP, APRV, SPONT) and volume‑targeted, adaptive pressure-controlled modes (APVcmv / (S)CMV+, APVsimv / SIMV+, VS).

Your HAMILTON‑T1 can also be equipped with the high flow nasal cannula therapy option. With this enhancement, the HAMILTON‑T1 offers you a variety of therapy options in one device, including invasive and noninvasive ventilation, and high flow nasal cannula therapy. In just a few steps, you can change the interface and use the same device and breathing circuit to accommodate your patient’s needs.

Patient interventions during transport are not always possible. The nCPAP mode on the HAMILTON‑T1 is designed in such a way that you only need to set the desired CPAP pressure. The flow is subsequently adjusted automatically based on the patient condition and variation in leakage, which prevents unintended peak pressures and guarantees leak compensation. Flow adjustment occurs with a minimum of delay due to the highly sensitive, proximal pressure measurement.

In addition to the standard nCPAP mode, the HAMILTON‑T1 with the neonatal option also features the biphasic nCPAP‑PC (pressure-controlled) mode. This mode allows you to set two pressure levels, as well as the rate and inspiratory time. The flow is also adjusted as needed in this mode. The modern pneumatic concept of the HAMILTON‑T1 enables the patient to breathe freely at any time on both pressure levels. 

In Volume Support mode, breaths are volume targeted and spontaneous. Pressure is adjusted between breaths to achieve the target tidal volume.

Neonatal patient transported with an HAMILTON-T1 neonatal transport ventilator

On land, at sea, and in the air. Approved for all types of transport

The HAMILTON-T1 meets the transport standards EN 794-3 and ISO 10651-3 for emergency and transport ventilators, EN 1789 for ambulances and EN 13718-1 as well as RTCA/DO-160G for aircraft. It reliably accompanies your patients anywhere within or outside of the hospital, on the ground, at sea and in the air.

Upgrade or buy new. Get the neonatal option for the HAMILTON-T1

Book a free personal demonstration with one of our specialists to explore the benefits of our HAMILTON-T1 with the neonatal option. They can guide you through the features and functionalities based on your specific needs.

Alternatively, you can schedule a callback, and our team will reach out to provide you with the necessary information and assistance.

For more information

Document
HAMILTON-T1 brochure neonatal function Software version 3.0.x
anglais | 1,86 MB | 689522.02
Document
Neonatal ventilation brochure SW3.0.x
anglais | 1,57 MB | ELO20180806N.01
Document
Nuflow nasal cannula for oxygen therapy in pediatrics brochure USA Version
anglais | 0,61 MB | ELO20200103.00
Document
Technical specification for SW version 3.0.x
anglais | 0,25 MB | 10101903.02

Notes en bas de page

  • a. Non commercialisé dans certains pays

Références

  1. 1. Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666. Published 2010 Nov 10. doi:10.1002/14651858.CD003666.pub3

Volume-targeted versus pressure-limited ventilation in the neonate.

Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev. 2010;(11):CD003666. Published 2010 Nov 10. doi:10.1002/14651858.CD003666.pub3



BACKGROUND

Damage caused by lung overdistension (volutrauma) has been implicated in the development bronchopulmonary dysplasia (BPD). Modern neonatal ventilation modes can target a set tidal volume as an alternative to traditional pressure-limited ventilation using a fixed inflation pressure. Volume targeting aims to produce a more stable tidal volume in order to reduce lung damage and stabilise pCO(2)

OBJECTIVES

To determine whether volume-targeted ventilation (VTV) compared with pressure-limited ventilation (PLV) leads to reduced rates of death and BPD in newborn infants. Secondary objectives were to determine whether use of VTV affected outcomes including air leak, cranial ultrasound findings and neurodevelopment.

SEARCH STRATEGY

The search strategy comprised searches of the Cochrane Central Register of Controlled Trials, MEDLINE PubMed 1966 to January 2010, and hand searches of reference lists of relevant articles and conference proceedings.

SELECTION CRITERIA

All randomised and quasi-randomised trials comparing the use of volume-targeted versus pressure-limited ventilation in infants of less than 28 days corrected age.

DATA COLLECTION AND ANALYSIS

Two review authors assessed the methodological quality of eligible trials and extracted data independently. When appropriate, meta-analysis was conducted to provide a pooled estimate of effect. For categorical data the relative risk (RR) and risk difference (RD) were calculated with 95% confidence intervals. Number needed to treat was calculated when RD was statistically significant. Continuous data were analysed using weighted mean difference.

MAIN RESULTS

Twelve randomised trials met our inclusion criteria; nine parallel trials (629 infants) and three crossover trials (64 infants).The use of VTV modes resulted in a reduction in the combined outcome of death or bronchopulmonary dysplasia [typical RR 0.73 (95% CI 0.57 to 0.93), NNT8 (95% CI 5 to 33)]. VTV modes also resulted in reductions in pneumothorax [typical RR 0.46 (95% CI 0.25 to 0.84), NNT 17 (95% CI 10 to 100)], days of ventilation [MD -2.36 (95% CI -3.9 to -0.8)], hypocarbia [typical RR 0.56 (95%CI 0.33 to 0.96), NNT 4 (95% CI 2 to 25)] and the combined outcome of periventricular leukomalacia or grade 3-4 intraventricular haemorrhage [typical RR 0.48 (95% CI 0.28 to 0.84), NNT 11 (95% CI 7 to 50)].

AUTHORS' CONCLUSIONS

Infants ventilated using VTV modes had reduced death and chronic lung disease compared with infants ventilated using PLV modes. Further studies are needed to identify whether VTV modes improve neurodevelopmental outcomes and to compare and refine VTV strategies.